Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
University of Kansas National Cancer Institute (NCI) |
---|---|
Information provided by: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT00666978 |
RATIONALE: A stop-smoking plan that includes health education counseling and bupropion may help African-American smokers stop smoking. It is not yet known whether health education counseling is more effective with or without bupropion in helping African Americans stop smoking.
PURPOSE: This clinical trial is studying health education counseling and bupropion to see how well they work compared with a placebo and health education counseling in helping African Americans smokers stop smoking.
Condition | Intervention |
---|---|
Bladder Cancer Cancer-Related Problem/Condition Cervical Cancer Esophageal Cancer Gastric Cancer Head and Neck Cancer Kidney Cancer Leukemia Liver Cancer Lung Cancer Pancreatic Cancer |
Drug: bupropion hydrochloride Procedure: counseling Procedure: educational intervention Procedure: gene expression analysis Procedure: laboratory biomarker analysis Procedure: liquid chromatography Procedure: mass spectrometry Procedure: polymerase chain reaction Procedure: polymorphism analysis Procedure: psychosocial assessment and care Procedure: questionnaire administration Procedure: smoking cessation intervention Procedure: study of socioeconomic and demographic variables |
Study Type: | Observational |
Official Title: | Enhancing Tobacco Use Treatment for African American Light Smokers |
Estimated Enrollment: | 540 |
Study Start Date: | December 2007 |
Estimated Primary Completion Date: | April 2009 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
African American who has smoked ≤ 10 cigarettes per day for ≥ 2 years AND has smoked for ≥ 25 days within the past month
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
United States, Kansas | |
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center | Recruiting |
Kansas City, Kansas, United States, 66160-7357 | |
Contact: Clinical Trials Office - Kansas Masonic Cancer Research Instit 913-588-4709 | |
United States, Missouri | |
Swope Health Central | Recruiting |
Kansas City, Missouri, United States, 64130 | |
Contact: Contact Person 816-627-2122 |
Principal Investigator: | Lisa S. Cox, PhD | University of Kansas |
Study ID Numbers: | CDR0000581423, KUMC-HSC-10332, KUMC-070313 |
Study First Received: | April 24, 2008 |
Last Updated: | December 16, 2008 |
ClinicalTrials.gov Identifier: | NCT00666978 |
Health Authority: | Unspecified |
bladder cancer cervical cancer esophageal cancer gastric cancer renal cell carcinoma adult primary liver cancer non-small cell lung cancer small cell lung cancer pancreatic cancer |
hypopharyngeal cancer laryngeal cancer lip and oral cavity cancer nasopharyngeal cancer oropharyngeal cancer paranasal sinus and nasal cavity cancer adult acute myeloid leukemia tobacco use disorder |
Thoracic Neoplasms Liver Diseases Pancreatic Neoplasms Urogenital Neoplasms Urologic Neoplasms Smoking Dopamine Lung Neoplasms Oral cancer Laryngeal carcinoma Acute myeloid leukemia, adult Kidney Diseases Endocrine Gland Neoplasms Non-small cell lung cancer Digestive System Neoplasms |
Tobacco Use Disorder Urinary Bladder Diseases Urinary Bladder Neoplasms Acute myelogenous leukemia Endocrine System Diseases Stomach cancer Renal cancer Leukemia, Myeloid Lip and oral cavity cancer Carcinoma Carcinoma, Small Cell Lung Diseases Gastrointestinal Neoplasms Pancreatic Diseases Esophageal Diseases |
Dopamine Uptake Inhibitors Respiratory Tract Neoplasms Neurotransmitter Uptake Inhibitors Neurotransmitter Agents Neoplasms by Histologic Type Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Psychotropic Drugs |
Pharmacologic Actions Neoplasms Neoplasms by Site Therapeutic Uses Dopamine Agents Antidepressive Agents, Second-Generation Central Nervous System Agents Antidepressive Agents |